HeartSciences Inc. (HSCS): Nasdaq/NYSE listing notice — Heart Test Labs receives Nasdaq deficiency notice for failing minimum equity requirement

HeartSciences Inc.

Nasdaq letter dated Dec 21, 2022: stockholders' equity ($1.08M) below $2.5M minimum required by Listing Rule 5550(b)(1).
Company has 45 days (until Feb 3, 2023) to submit a compliance plan; Nasdaq may grant up to 180 days to regain compliance.
If plan not accepted or compliance not regained, trading suspension or delisting risk, negatively impacting liquidity and financing.
Company intends to take measures to regain compliance; is evaluating options.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

HeartSciences Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

December 21, 2022, Heart Test Laboratories, Inc (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its quarterly report for the period ended October 31, 2022, the Company reported stockholders’ equity of $1,082,676, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing of the Com

View on SEC.gov

Browse all listing & compliance notices →

HeartSciences Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-027017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.